Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model

Pharmacological Research

Volumn 60, Issue 4, 2009, Pages 320-323

  Hagimori, Masayori ^a   Kamiya, Seitaro ^a   Yamaguchi, Yasuchika ^a   Arakawa, Masayuki ^a  

^a NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Antithrombotic effect; Carrageenan; Ligation; Tail thrombosis model

Indexed keywords

CARRAGEENAN; HEPARIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; ENDOTHELIUM INJURY; FEMALE; HYPERCOAGULABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOSIS;

ANIMALS; ANTICOAGULANTS; BLOOD FLOW VELOCITY; CARRAGEENAN; COLD TEMPERATURE; DISEASE MODELS, ANIMAL; FEMALE; HEPARIN; LIGATION; RATS; RATS, WISTAR; THROMBOSIS;

EID: 69249211170     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.04.010     Document Type: Article

References (18)

1. Winter C.A., Risley E.A., and Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111 (1962) 544-547
2. Tobacman J.K. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect 109 (2001) 983-994
3. Tobacman J.K., Wallace R.B., and Zimmerman M.B. Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma. Med Hypotheses 56 (2001) 589-598
4. Carthew P. Safety of carrageenan in foods. Environ Health Perspect 110 (2002) 176-177
5. Nicklin S., and Miller K. Intestinal uptake and immunological effects of carrageenan-current concepts. Food Addit Contam 6 (1989) 425-436
6. Zhang Y., Shaffer A., Portanova J., Seibert K., and Isakson P.C. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J Phamacol Exp Ther 283 (1997) 1069-1075
7. Li W.G., Zhang X.Y., Wu Y.J., and Tian X. Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds. Acta Pharmacol Sin 22 (2001) 1117-1120
8. Nantel F., Denis D., Gordon R., Northey A., Cirino M., Metters K.M., et al. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Brit J Pharmacol 128 (1999) 853-859
9. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349 (1997) 1269-1276
10. Bekemeier H., Hirschelmann R., and Giessler A.J. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?. Agents Actions 16 (1985) 446-451
11. Bekemeier H., and Giessler A.J. Thrombosis induction by different carrageenans in rats and mice. Naturwissenschaften 74 (1987) 345-346
12. Bertelli A., Giovannini L., Galmozzi G., and Bertelli A.A.E. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and k-carrageenin. Drugs Exp Clin Res 19 (1993) 7-11
13. Bekemeier H., Gabor M., and Hirschelmann R. Influence of flavonoids and lanthanides on kappa-carrageenin rat tail thrombosis. Exp Pathol 40 (1990) 61-63
14. Hara H., Shimada H., Kitajima A., and Tamao Y. Effect of (±)-2-(dimethylamino)-1-[[o-(m-methoxy-phenethyl)phenoxy]methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. Arzneim-Forsch/Drug Res 41 (1991) 616-620
15. Virchow R. Gesammelte Abhandlungen zur wissenschaftlichen Medizin (1856), Meidinger Sohn, Frankfurt
16. Bertelli A., Bertelli A.A.E., Galmozzi G., Giovannini L., and Mian M. Thrombosis induced by endothelin (ET-1) and carrageenin in rats treated with indomethacin and propionyl carnitine. Drugs Exp Clin Res 19 (1993) 75-78
17. Bekemeier H., and Hirschelmann R. Influence of serotonin, serotonin antagonists, some vasoactive substances and temperature on carrageenin-induced tail thrombosis in rats and mice. Agents Actions 18 (1986) 581-585
18. Gervasi G.B., Bartoli C., and Carpita G. A new low molecular weight heparin sulphate antagonizes κ-carrageenan-induced thrombosis in rats. Pharmacol Res 24 (1991) 59-63